Lincoln National Corp West Pharmaceutical Services Inc Transaction History

Lincoln National Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$338.27 - $413.0 $37,209 - $45,430	-110 Reduced 5.2%	2,004 $793,000
Q4 2023 Feb 06, 2024	BUY	$318.29 - $392.21 $98,669 - $121,585	310 Added 17.18%	2,114 $744,000
Q3 2023 Nov 03, 2023	BUY	$354.9 - $412.41 $22,713 - $26,394	64 Added 3.68%	1,804 $676,000
Q2 2023 Aug 04, 2023	SELL	$334.63 - $382.47 $24,093 - $27,537	-72 Reduced 3.97%	1,740 $665,000
Q1 2023 May 01, 2023	BUY	$232.5 - $346.47 $15,345 - $22,867	66 Added 3.78%	1,812 $627,000
Q4 2022 Feb 07, 2023	BUY	$209.34 - $261.61 $4,605 - $5,755	22 Added 1.28%	1,746 $410,000
Q3 2022 Nov 03, 2022	BUY	$246.08 - $343.65 $114,181 - $159,453	464 Added 36.83%	1,724 $424,000
Q2 2022 Aug 02, 2022	BUY	$280.61 - $420.45 $37,040 - $55,499	132 Added 11.7%	1,260 $381,000
Q1 2022 May 09, 2022	BUY	$357.49 - $445.92 $90,802 - $113,263	254 Added 29.06%	1,128 $463,000
Q3 2021 Nov 05, 2021	BUY	$363.01 - $468.47 $91,841 - $118,522	253 Added 40.74%	874 $371,000
Q2 2021 Aug 13, 2021	BUY	$284.77 - $363.2 $176,842 - $225,547	621 New	621 $223,000

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.